Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Eur J Pharm Sci. 2018 Jan 10;126:3–10. doi: 10.1016/j.ejps.2018.01.020

Figure 5.

Figure 5

(A) Various drug release rates from microsphere and FFA combinations, (B) Various drug release rates from a single FFA formulation, and (C) Drug release rates of betamethasone from microspheres of different sizes, when suspended in an FFA component. The microsphere component retains drug and releases it over long periods of time, whereas the FFA component makes the drug readily available for therapeutic effect.